Protein partnership may fend off pancreatic cancer progression

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA replication in cancer cells.

March 13, 2026

Vol.52 No.10

Clinical Roundup

Nutrition therapy extends survival by 34% in stage 4 pancreatic cancer patients, clinical trial shows

Medically supervised, individualized nutrition therapy—long proven effective in reversing metabolic diseases like type 2 diabetes and obesity—shows promise in extending survival in patients with metastatic pancreatic cancer when used alongside chemotherapy, according to data from a randomized, controlled phase II clinical trial.

March 13, 2026

Vol.52 No.10

Black History Month Podcast

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

Malcolm V. Brock, director of Clinical and Translational Research in Thoracic Surgery at Johns Hopkins Kimmel Comprehensive Cancer Center, grew up in Bermuda. His father insisted that his children branch outside the small island—the country has a population of just over 60,000 people—and challenge themselves abroad.

February 20, 2026

Vol.52 No.07

By Malcolm V. Brock, Robert A. Winn and Preston Willett

Drugs & Targets

FDA approves pancreatic cancer device

FDA approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic cancer. Optune Pax, developed by Novocure, is a portable, non-invasive device that delivers alternating electrical fields, known as tumor treating fields, to the abdomen.

February 20, 2026

Vol.52 No.07

Clinical Roundup

Immunity against CMV leveraged against pancreatic cancer in study by UCSD, La Jolla Institute of Immunology

Researchers at the University of California San Diego and La Jolla Institute of Immunology have discovered a promising treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The approach leverages the body’s natural immune response to cytomegalovirus, a common but typically harmless virus that most people are infected with at some point in their lives.

February 13, 2026

Vol.52 No.06

In Brief

Dimple Patel joins VCU Massey as associate director for innovation, leadership, and professional development

Dimple Patel recently joined the executive leadership team at VCU Massey Comprehensive Cancer Center, where she will serve as the associate director for innovation, leadership, and professional development. Patel brings 25 years of leadership experience spanning six public and private institutions of higher education.

December 19, 2025

Vol.51 No.46

Protein partnership may fend off pancreatic cancer progression

YOU MAY BE INTERESTED IN

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Nutrition therapy extends survival by 34% in stage 4 pancreatic cancer patients, clinical trial shows

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

FDA approves pancreatic cancer device

Immunity against CMV leveraged against pancreatic cancer in study by UCSD, La Jolla Institute of Immunology

Dimple Patel joins VCU Massey as associate director for innovation, leadership, and professional development

Renew today!

Subscriber content

Never miss an issue!

Login

Protein partnership may fend off pancreatic cancer progression

YOU MAY BE INTERESTED IN

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Nutrition therapy extends survival by 34% in stage 4 pancreatic cancer patients, clinical trial shows

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology“When it gets down to brass tacks, relationships between each other, we’re all one.”

FDA approves pancreatic cancer device

Immunity against CMV leveraged against pancreatic cancer in study by UCSD, La Jolla Institute of Immunology

Dimple Patel joins VCU Massey as associate director for innovation, leadership, and professional development

Never miss an issue!

Login

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”